{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:22:18Z","timestamp":1760487738555,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bbadis.2023.166658","type":"journal-article","created":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T01:08:12Z","timestamp":1674954492000},"page":"166658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The ovine Type II Gaucher disease model recapitulates aspects of human brain disease."],"prefix":"10.1016","volume":"1869","author":[{"given":"Leanne K.","family":"Winner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Litsa","family":"Karageorgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim M.","family":"Hemsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbadis.2023.166658_bb0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20043","article-title":"Functional analysis of 13 GBA mutant alleles identified in gaucher disease patients: pathogenic changes and \"modifier\" polymorphisms","volume":"23","author":"Montfort","year":"2004","journal-title":"Hum. Mutat."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166658_bb0010","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"J. Clin. Invest."},{"issue":"7503","key":"10.1016\/j.bbadis.2023.166658_bb0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature13476","article-title":"Sphingolipid lysosomal storage disorders","volume":"510","author":"Platt","year":"2014","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2023.166658_bb0020","first-page":"S6","article-title":"Understanding the natural history of Gaucher disease","volume":"90","author":"Mistry","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166658_bb0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic gaucher disease: demographic and clinical features of 131 patients enrolled in the international collaborative gaucher group neurological outcomes subregistry","volume":"33","author":"Tylki-Szymanska","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"18","key":"10.1016\/j.bbadis.2023.166658_bb0030","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The gaucher registry: demographics and disease characteristics of 1698 patients with gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166658_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","article-title":"The incidence of parkinsonism in patients with type 1 gaucher disease: data from the ICGG gaucher registry","volume":"46","author":"Rosenbloom","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166658_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.410200208","article-title":"Type 2 and type 3 gaucher disease: a morphological and biochemical study","volume":"20","author":"Kaye","year":"1986","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166658_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/mgme.1999.2918","article-title":"Type 2 gaucher disease: an expanding phenotype","volume":"68","author":"Tayebi","year":"1999","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166658_bb0050","doi-asserted-by":"crossref","first-page":"F163","DOI":"10.1136\/fn.82.2.F163","article-title":"Type 2 gaucher disease: the collodion baby phenotype revisited","volume":"82","author":"Stone","year":"2000","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166658_bb0055","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1194\/jlr.R800002-JLR200","article-title":"Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism","volume":"49","author":"Elias","year":"2008","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166658_bb0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000324116","article-title":"Congenital ichthyosis in severe type II gaucher disease with a homozygous null mutation","volume":"100","author":"Haverkaemper","year":"2011","journal-title":"Neonatology"},{"issue":"9645","key":"10.1016\/j.bbadis.2023.166658_bb0065","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.bbadis.2023.166658_bb0070","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"1433","key":"10.1016\/j.bbadis.2023.166658_bb0075","first-page":"955","article-title":"Substrate reduction therapy: clinical evaluation in type 1 gaucher disease","volume":"358","author":"Moyses","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166658_bb0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166658_bb0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005072-195704000-00003","article-title":"Neuropathologic findings in a case of infantile Gaucher's disease","volume":"16","author":"Barlow","year":"1957","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"46","key":"10.1016\/j.bbadis.2023.166658_bb0090","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1523\/JNEUROSCI.4527-15.2016","article-title":"A drosophila model of neuronopathic gaucher disease demonstrates lysosomal-autophagic defects and altered mTOR signalling and is functionally rescued by rapamycin","volume":"36","author":"Kinghorn","year":"2016","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166658_bb0095","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","article-title":"Mitochondria and quality control defects in a mouse model of gaucher disease\u2013links to Parkinson's disease","volume":"17","author":"Osellame","year":"2013","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166658_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162367","article-title":"Progression of behavioral and CNS deficits in a viable murine model of chronic neuronopathic gaucher disease","volume":"11","author":"Dai","year":"2016","journal-title":"PLoS One"},{"issue":"2\u20133","key":"10.1016\/j.bbadis.2023.166658_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02962142","article-title":"A biochemical and ultrastructural evaluation of the type 2 gaucher mouse","volume":"24","author":"Willemsen","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"issue":"44","key":"10.1016\/j.bbadis.2023.166658_bb0110","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6377","key":"10.1016\/j.bbadis.2023.166658_bb0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"Tybulewicz","year":"1992","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166658_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-010-9230-3","article-title":"Gaucher disease in sheep","volume":"34","author":"Karageorgos","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166658_bb0125","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI117160","article-title":"Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in gaucher disease","volume":"93","author":"Holleran","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2023.166658_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nbd.2016.03.011","article-title":"Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic gaucher disease","volume":"91","author":"Karageorgos","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166658_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-1119(90)90264-R","article-title":"Prevalent and rare mutations among gaucher patients","volume":"96","author":"Eyal","year":"1990","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166658_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s004010050796","article-title":"Lectin histochemistry in the aged dog brain","volume":"95","author":"Kiatipattanasakul","year":"1998","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166658_bb0145","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.bbadis.2023.166658_bb0150","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1093\/hmg\/ddq273","article-title":"Altered expression and distribution of cathepsins in neuronopathic forms of gaucher disease and in other sphingolipidoses","volume":"19","author":"Vitner","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166658_bb0155","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","article-title":"Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic gaucher disease","volume":"20","author":"Farfel-Becker","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166658_bb0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11259-014-9614-1","article-title":"Developmental profiles of GFAP-positive astrocytes in sheep cerebellum","volume":"38","author":"Salouci","year":"2014","journal-title":"Vet. Res. Commun."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166658_bb0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajmg.a.20117","article-title":"Perinatal-lethal gaucher disease","volume":"120A","author":"Mignot","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166658_bb0170","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1096-8628(20000320)91:3<222::AID-AJMG13>3.0.CO;2-#","article-title":"Severe type II gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses","volume":"91","author":"Finn","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166658_bb0175","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2023.166658_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pneurobio.2015.07.003","article-title":"Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies","volume":"155","author":"Bourdenx","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166658_bb0185","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/nmo.12933","article-title":"Intestinal dysfunction in Parkinson's disease: lessons learned from translational studies and experimental models","volume":"28","author":"Pellegrini","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166658_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbapap.2016.12.008","article-title":"Analysis of sheep alpha-synuclein provides a molecular strategy for the reduction of fibrillation","volume":"1865","author":"Bickle","year":"2017","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"issue":"15","key":"10.1016\/j.bbadis.2023.166658_bb2000","doi-asserted-by":"crossref","first-page":"e2119","DOI":"10.1212\/WNL.0000000000010605","article-title":"The natural history of type 2 Gaucher disease inthe 21st century: A retrospective study","volume":"95","author":"Roshan Lal","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166658_bb2005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12974-020-01934-x","article-title":"Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease","volume":"17","author":"Vardi","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"15","key":"10.1016\/j.bbadis.2023.166658_bb2010","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/hmg\/ddu105","article-title":"Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice","volume":"23","author":"Xu","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166658_bb2015","doi-asserted-by":"crossref","first-page":"e1005065","DOI":"10.1371\/journal.pgen.1005065","article-title":"Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein","volume":"11","author":"Uemura","year":"2015","journal-title":"PLoS Genet."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:12:39Z","timestamp":1760418759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0925443923000248"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166658","relation":{},"ISSN":["0925-4439"],"issn-type":[{"type":"print","value":"0925-4439"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ovine Type II Gaucher disease model recapitulates aspects of human brain disease.","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166658"}}